SMITH & NEPHEW PLCSMITH & NEPHEW PLCSMITH & NEPHEW PLC

SMITH & NEPHEW PLC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪215.42 B‬MXN
6.43MXN
‪4.57 B‬MXN
‪96.52 B‬MXN
‪844.31 M‬
Beta (1Y)
0.70
Employees (FY)
‪19.55 K‬
Change (1Y)
−571 −2.84%
Revenue / Employee (1Y)
‪4.94 M‬MXN
Net income / Employee (1Y)
‪233.99 K‬MXN

About SMITH & NEPHEW PLC ORD USD0.20


CEO
Deepak S Nath
Headquarters
Watford
Founded
1856
ISIN
GB0009223206
FIGI
BBG010VNCZ48
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
SNN5059246
Smith & Nephew plc 2.032% 14-OCT-2030
Yield to maturity
5.79%
Maturity date
Oct 14, 2030
SNN5772776
Smith & Nephew plc 5.4% 20-MAR-2034
Yield to maturity
5.58%
Maturity date
Mar 20, 2034
SNN5772775
Smith & Nephew plc 5.15% 20-MAR-2027
Yield to maturity
4.83%
Maturity date
Mar 20, 2027
XS253247355
SMITH&NEPHEW 22/29
Yield to maturity
3.28%
Maturity date
Oct 11, 2029

Explore more bonds 

Frequently Asked Questions


The current price of SN1/N is 290.15 MXN — it hasn't changed in the past 24 hours. Watch SMITH & NEPHEW PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange SMITH & NEPHEW PLC stocks are traded under the ticker SN1/N.
SN1/N stock hasn't changed in a week, the last month showed zero change in price, over the last year SMITH & NEPHEW PLC has showed a 34.41% increase.
We've gathered analysts' opinions on SMITH & NEPHEW PLC future price: according to them, SN1/N price has a max estimate of 381.89 MXN and a min estimate of 264.73 MXN. Watch SN1/N chart and read a more detailed SMITH & NEPHEW PLC stock forecast: see what analysts think of SMITH & NEPHEW PLC and suggest that you do with its stocks.
SN1/N reached its all-time high on May 7, 2021 with the price of 440.50 MXN, and its all-time low was 199.78 MXN and was reached on Apr 12, 2024. View more price dynamics on SN1/N chart.
See other stocks reaching their highest and lowest prices.
SN1/N stock is 0.00% volatile and has beta coefficient of 0.70. Track SMITH & NEPHEW PLC stock price on the chart and check out the list of the most volatile stocks — is SMITH & NEPHEW PLC there?
Today SMITH & NEPHEW PLC has the market capitalization of ‪217.47 B‬, it has decreased by −1.24% over the last week.
Yes, you can track SMITH & NEPHEW PLC financials in yearly and quarterly reports right on TradingView.
SMITH & NEPHEW PLC is going to release the next earnings report on Feb 25, 2025. Keep track of upcoming events with our Earnings Calendar.
SN1/N earnings for the last half-year are 6.90 MXN per share, whereas the estimation was 7.20 MXN, resulting in a −4.28% surprise. The estimated earnings for the next half-year are 9.28 MXN per share. See more details about SMITH & NEPHEW PLC earnings.
SMITH & NEPHEW PLC revenue for the last half-year amounts to ‪51.85 B‬ MXN, despite the estimated figure of ‪51.82 B‬ MXN. In the next half-year revenue is expected to reach ‪59.78 B‬ MXN.
SN1/N net income for the last half-year is ‪3.92 B‬ MXN, while the previous report showed ‪1.57 B‬ MXN of net income which accounts for 149.87% change. Track more SMITH & NEPHEW PLC financial stats to get the full picture.
SMITH & NEPHEW PLC dividend yield was 2.82% in 2023, and payout ratio reached 125.07%. The year before the numbers were 2.82% and 150.72% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 25, 2024, the company has ‪19.55 K‬ employees. See our rating of the largest employees — is SMITH & NEPHEW PLC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SMITH & NEPHEW PLC EBITDA is ‪27.48 B‬ MXN, and current EBITDA margin is 26.38%. See more stats in SMITH & NEPHEW PLC financial statements.
Like other stocks, SN1/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SMITH & NEPHEW PLC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SMITH & NEPHEW PLC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SMITH & NEPHEW PLC stock shows the buy signal. See more of SMITH & NEPHEW PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.